Global Choroidal Neovascularization Market Research Report 2025(Status and Outlook)
Report Overview
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub?retinal pigment epithelium (sub-RPE) or subretinal space.
This report provides a deep insight into the global Choroidal Neovascularization market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Choroidal Neovascularization Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Choroidal Neovascularization market in any manner.
Global Choroidal Neovascularization Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Market Segmentation (by Type)
Intravenous
Intravitreal
Market Segmentation (by Application)
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Choroidal Neovascularization Market
Overview of the regional outlook of the Choroidal Neovascularization Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Choroidal Neovascularization Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Choroidal Neovascularization, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub?retinal pigment epithelium (sub-RPE) or subretinal space.
This report provides a deep insight into the global Choroidal Neovascularization market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Choroidal Neovascularization Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Choroidal Neovascularization market in any manner.
Global Choroidal Neovascularization Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Bayer AG
QLT Inc.
Sanwa Kagaku Kenkyusho Co. Ltd.
Promedior Inc.
Bausch Health
Gilead Sciences Inc
Market Segmentation (by Type)
Intravenous
Intravitreal
Market Segmentation (by Application)
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Choroidal Neovascularization Market
Overview of the regional outlook of the Choroidal Neovascularization Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Choroidal Neovascularization Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Choroidal Neovascularization, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Choroidal Neovascularization
1.2 Key Market Segments
1.2.1 Choroidal Neovascularization Segment by Type
1.2.2 Choroidal Neovascularization Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOROIDAL NEOVASCULARIZATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Choroidal Neovascularization Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Choroidal Neovascularization Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOROIDAL NEOVASCULARIZATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Choroidal Neovascularization Product Life Cycle
3.3 Global Choroidal Neovascularization Sales by Manufacturers (2020-2025)
3.4 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2020-2025)
3.5 Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Choroidal Neovascularization Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Choroidal Neovascularization Market Competitive Situation and Trends
3.8.1 Choroidal Neovascularization Market Concentration Rate
3.8.2 Global 5 and 10 Largest Choroidal Neovascularization Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHOROIDAL NEOVASCULARIZATION INDUSTRY CHAIN ANALYSIS
4.1 Choroidal Neovascularization Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Choroidal Neovascularization Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Choroidal Neovascularization Market
5.7 ESG Ratings of Leading Companies
6 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Choroidal Neovascularization Sales Market Share by Type (2020-2025)
6.3 Global Choroidal Neovascularization Market Size Market Share by Type (2020-2025)
6.4 Global Choroidal Neovascularization Price by Type (2020-2025)
7 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Choroidal Neovascularization Market Sales by Application (2020-2025)
7.3 Global Choroidal Neovascularization Market Size (M USD) by Application (2020-2025)
7.4 Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
8 CHOROIDAL NEOVASCULARIZATION MARKET SALES BY REGION
8.1 Global Choroidal Neovascularization Sales by Region
8.1.1 Global Choroidal Neovascularization Sales by Region
8.1.2 Global Choroidal Neovascularization Sales Market Share by Region
8.2 Global Choroidal Neovascularization Market Size by Region
8.2.1 Global Choroidal Neovascularization Market Size by Region
8.2.2 Global Choroidal Neovascularization Market Size Market Share by Region
8.3 North America
8.3.1 North America Choroidal Neovascularization Sales by Country
8.3.2 North America Choroidal Neovascularization Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Choroidal Neovascularization Sales by Country
8.4.2 Europe Choroidal Neovascularization Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Choroidal Neovascularization Sales by Region
8.5.2 Asia Pacific Choroidal Neovascularization Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Choroidal Neovascularization Sales by Country
8.6.2 South America Choroidal Neovascularization Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Choroidal Neovascularization Sales by Region
8.7.2 Middle East and Africa Choroidal Neovascularization Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHOROIDAL NEOVASCULARIZATION MARKET PRODUCTION BY REGION
9.1 Global Production of Choroidal Neovascularization by Region(2020-2025)
9.2 Global Choroidal Neovascularization Revenue Market Share by Region (2020-2025)
9.3 Global Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Choroidal Neovascularization Production
9.4.1 North America Choroidal Neovascularization Production Growth Rate (2020-2025)
9.4.2 North America Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Choroidal Neovascularization Production
9.5.1 Europe Choroidal Neovascularization Production Growth Rate (2020-2025)
9.5.2 Europe Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Choroidal Neovascularization Production (2020-2025)
9.6.1 Japan Choroidal Neovascularization Production Growth Rate (2020-2025)
9.6.2 Japan Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Choroidal Neovascularization Production (2020-2025)
9.7.1 China Choroidal Neovascularization Production Growth Rate (2020-2025)
9.7.2 China Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Basic Information
10.1.2 Pfizer Inc. Choroidal Neovascularization Product Overview
10.1.3 Pfizer Inc. Choroidal Neovascularization Product Market Performance
10.1.4 Pfizer Inc. Business Overview
10.1.5 Pfizer Inc. SWOT Analysis
10.1.6 Pfizer Inc. Recent Developments
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 F. Hoffmann-La Roche Ltd. Basic Information
10.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
10.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Market Performance
10.2.4 F. Hoffmann-La Roche Ltd. Business Overview
10.2.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Basic Information
10.3.2 Novartis AG Choroidal Neovascularization Product Overview
10.3.3 Novartis AG Choroidal Neovascularization Product Market Performance
10.3.4 Novartis AG Business Overview
10.3.5 Novartis AG SWOT Analysis
10.3.6 Novartis AG Recent Developments
10.4 Regeneron Pharmaceuticals Inc.
10.4.1 Regeneron Pharmaceuticals Inc. Basic Information
10.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
10.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Market Performance
10.4.4 Regeneron Pharmaceuticals Inc. Business Overview
10.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
10.5 Bayer AG
10.5.1 Bayer AG Basic Information
10.5.2 Bayer AG Choroidal Neovascularization Product Overview
10.5.3 Bayer AG Choroidal Neovascularization Product Market Performance
10.5.4 Bayer AG Business Overview
10.5.5 Bayer AG Recent Developments
10.6 QLT Inc.
10.6.1 QLT Inc. Basic Information
10.6.2 QLT Inc. Choroidal Neovascularization Product Overview
10.6.3 QLT Inc. Choroidal Neovascularization Product Market Performance
10.6.4 QLT Inc. Business Overview
10.6.5 QLT Inc. Recent Developments
10.7 Sanwa Kagaku Kenkyusho Co. Ltd.
10.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information
10.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
10.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Market Performance
10.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
10.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
10.8 Promedior Inc.
10.8.1 Promedior Inc. Basic Information
10.8.2 Promedior Inc. Choroidal Neovascularization Product Overview
10.8.3 Promedior Inc. Choroidal Neovascularization Product Market Performance
10.8.4 Promedior Inc. Business Overview
10.8.5 Promedior Inc. Recent Developments
10.9 Bausch Health
10.9.1 Bausch Health Basic Information
10.9.2 Bausch Health Choroidal Neovascularization Product Overview
10.9.3 Bausch Health Choroidal Neovascularization Product Market Performance
10.9.4 Bausch Health Business Overview
10.9.5 Bausch Health Recent Developments
10.10 Gilead Sciences Inc
10.10.1 Gilead Sciences Inc Basic Information
10.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Overview
10.10.3 Gilead Sciences Inc Choroidal Neovascularization Product Market Performance
10.10.4 Gilead Sciences Inc Business Overview
10.10.5 Gilead Sciences Inc Recent Developments
11 CHOROIDAL NEOVASCULARIZATION MARKET FORECAST BY REGION
11.1 Global Choroidal Neovascularization Market Size Forecast
11.2 Global Choroidal Neovascularization Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Choroidal Neovascularization Market Size Forecast by Country
11.2.3 Asia Pacific Choroidal Neovascularization Market Size Forecast by Region
11.2.4 South America Choroidal Neovascularization Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Choroidal Neovascularization by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Choroidal Neovascularization Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2026-2033)
12.1.2 Global Choroidal Neovascularization Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Choroidal Neovascularization by Type (2026-2033)
12.2 Global Choroidal Neovascularization Market Forecast by Application (2026-2033)
12.2.1 Global Choroidal Neovascularization Sales (K Units) Forecast by Application
12.2.2 Global Choroidal Neovascularization Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Choroidal Neovascularization
1.2 Key Market Segments
1.2.1 Choroidal Neovascularization Segment by Type
1.2.2 Choroidal Neovascularization Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHOROIDAL NEOVASCULARIZATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Choroidal Neovascularization Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Choroidal Neovascularization Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHOROIDAL NEOVASCULARIZATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Choroidal Neovascularization Product Life Cycle
3.3 Global Choroidal Neovascularization Sales by Manufacturers (2020-2025)
3.4 Global Choroidal Neovascularization Revenue Market Share by Manufacturers (2020-2025)
3.5 Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Choroidal Neovascularization Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Choroidal Neovascularization Market Competitive Situation and Trends
3.8.1 Choroidal Neovascularization Market Concentration Rate
3.8.2 Global 5 and 10 Largest Choroidal Neovascularization Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHOROIDAL NEOVASCULARIZATION INDUSTRY CHAIN ANALYSIS
4.1 Choroidal Neovascularization Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHOROIDAL NEOVASCULARIZATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Choroidal Neovascularization Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Choroidal Neovascularization Market
5.7 ESG Ratings of Leading Companies
6 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Choroidal Neovascularization Sales Market Share by Type (2020-2025)
6.3 Global Choroidal Neovascularization Market Size Market Share by Type (2020-2025)
6.4 Global Choroidal Neovascularization Price by Type (2020-2025)
7 CHOROIDAL NEOVASCULARIZATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Choroidal Neovascularization Market Sales by Application (2020-2025)
7.3 Global Choroidal Neovascularization Market Size (M USD) by Application (2020-2025)
7.4 Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
8 CHOROIDAL NEOVASCULARIZATION MARKET SALES BY REGION
8.1 Global Choroidal Neovascularization Sales by Region
8.1.1 Global Choroidal Neovascularization Sales by Region
8.1.2 Global Choroidal Neovascularization Sales Market Share by Region
8.2 Global Choroidal Neovascularization Market Size by Region
8.2.1 Global Choroidal Neovascularization Market Size by Region
8.2.2 Global Choroidal Neovascularization Market Size Market Share by Region
8.3 North America
8.3.1 North America Choroidal Neovascularization Sales by Country
8.3.2 North America Choroidal Neovascularization Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Choroidal Neovascularization Sales by Country
8.4.2 Europe Choroidal Neovascularization Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Choroidal Neovascularization Sales by Region
8.5.2 Asia Pacific Choroidal Neovascularization Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Choroidal Neovascularization Sales by Country
8.6.2 South America Choroidal Neovascularization Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Choroidal Neovascularization Sales by Region
8.7.2 Middle East and Africa Choroidal Neovascularization Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHOROIDAL NEOVASCULARIZATION MARKET PRODUCTION BY REGION
9.1 Global Production of Choroidal Neovascularization by Region(2020-2025)
9.2 Global Choroidal Neovascularization Revenue Market Share by Region (2020-2025)
9.3 Global Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Choroidal Neovascularization Production
9.4.1 North America Choroidal Neovascularization Production Growth Rate (2020-2025)
9.4.2 North America Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Choroidal Neovascularization Production
9.5.1 Europe Choroidal Neovascularization Production Growth Rate (2020-2025)
9.5.2 Europe Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Choroidal Neovascularization Production (2020-2025)
9.6.1 Japan Choroidal Neovascularization Production Growth Rate (2020-2025)
9.6.2 Japan Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Choroidal Neovascularization Production (2020-2025)
9.7.1 China Choroidal Neovascularization Production Growth Rate (2020-2025)
9.7.2 China Choroidal Neovascularization Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Basic Information
10.1.2 Pfizer Inc. Choroidal Neovascularization Product Overview
10.1.3 Pfizer Inc. Choroidal Neovascularization Product Market Performance
10.1.4 Pfizer Inc. Business Overview
10.1.5 Pfizer Inc. SWOT Analysis
10.1.6 Pfizer Inc. Recent Developments
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 F. Hoffmann-La Roche Ltd. Basic Information
10.2.2 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
10.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Market Performance
10.2.4 F. Hoffmann-La Roche Ltd. Business Overview
10.2.5 F. Hoffmann-La Roche Ltd. SWOT Analysis
10.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
10.3 Novartis AG
10.3.1 Novartis AG Basic Information
10.3.2 Novartis AG Choroidal Neovascularization Product Overview
10.3.3 Novartis AG Choroidal Neovascularization Product Market Performance
10.3.4 Novartis AG Business Overview
10.3.5 Novartis AG SWOT Analysis
10.3.6 Novartis AG Recent Developments
10.4 Regeneron Pharmaceuticals Inc.
10.4.1 Regeneron Pharmaceuticals Inc. Basic Information
10.4.2 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
10.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Market Performance
10.4.4 Regeneron Pharmaceuticals Inc. Business Overview
10.4.5 Regeneron Pharmaceuticals Inc. Recent Developments
10.5 Bayer AG
10.5.1 Bayer AG Basic Information
10.5.2 Bayer AG Choroidal Neovascularization Product Overview
10.5.3 Bayer AG Choroidal Neovascularization Product Market Performance
10.5.4 Bayer AG Business Overview
10.5.5 Bayer AG Recent Developments
10.6 QLT Inc.
10.6.1 QLT Inc. Basic Information
10.6.2 QLT Inc. Choroidal Neovascularization Product Overview
10.6.3 QLT Inc. Choroidal Neovascularization Product Market Performance
10.6.4 QLT Inc. Business Overview
10.6.5 QLT Inc. Recent Developments
10.7 Sanwa Kagaku Kenkyusho Co. Ltd.
10.7.1 Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information
10.7.2 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
10.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Market Performance
10.7.4 Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
10.7.5 Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
10.8 Promedior Inc.
10.8.1 Promedior Inc. Basic Information
10.8.2 Promedior Inc. Choroidal Neovascularization Product Overview
10.8.3 Promedior Inc. Choroidal Neovascularization Product Market Performance
10.8.4 Promedior Inc. Business Overview
10.8.5 Promedior Inc. Recent Developments
10.9 Bausch Health
10.9.1 Bausch Health Basic Information
10.9.2 Bausch Health Choroidal Neovascularization Product Overview
10.9.3 Bausch Health Choroidal Neovascularization Product Market Performance
10.9.4 Bausch Health Business Overview
10.9.5 Bausch Health Recent Developments
10.10 Gilead Sciences Inc
10.10.1 Gilead Sciences Inc Basic Information
10.10.2 Gilead Sciences Inc Choroidal Neovascularization Product Overview
10.10.3 Gilead Sciences Inc Choroidal Neovascularization Product Market Performance
10.10.4 Gilead Sciences Inc Business Overview
10.10.5 Gilead Sciences Inc Recent Developments
11 CHOROIDAL NEOVASCULARIZATION MARKET FORECAST BY REGION
11.1 Global Choroidal Neovascularization Market Size Forecast
11.2 Global Choroidal Neovascularization Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Choroidal Neovascularization Market Size Forecast by Country
11.2.3 Asia Pacific Choroidal Neovascularization Market Size Forecast by Region
11.2.4 South America Choroidal Neovascularization Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Choroidal Neovascularization by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Choroidal Neovascularization Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Choroidal Neovascularization by Type (2026-2033)
12.1.2 Global Choroidal Neovascularization Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Choroidal Neovascularization by Type (2026-2033)
12.2 Global Choroidal Neovascularization Market Forecast by Application (2026-2033)
12.2.1 Global Choroidal Neovascularization Sales (K Units) Forecast by Application
12.2.2 Global Choroidal Neovascularization Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Choroidal Neovascularization Market Size Comparison by Region (M USD)
Table 5. Global Choroidal Neovascularization Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Choroidal Neovascularization Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Choroidal Neovascularization Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2024)
Table 10. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Choroidal Neovascularization Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Choroidal Neovascularization Sales by Type (K Units)
Table 26. Global Choroidal Neovascularization Market Size by Type (M USD)
Table 27. Global Choroidal Neovascularization Sales (K Units) by Type (2020-2025)
Table 28. Global Choroidal Neovascularization Sales Market Share by Type (2020-2025)
Table 29. Global Choroidal Neovascularization Market Size (M USD) by Type (2020-2025)
Table 30. Global Choroidal Neovascularization Market Size Share by Type (2020-2025)
Table 31. Global Choroidal Neovascularization Price (USD/Unit) by Type (2020-2025)
Table 32. Global Choroidal Neovascularization Sales (K Units) by Application
Table 33. Global Choroidal Neovascularization Market Size by Application
Table 34. Global Choroidal Neovascularization Sales by Application (2020-2025) & (K Units)
Table 35. Global Choroidal Neovascularization Sales Market Share by Application (2020-2025)
Table 36. Global Choroidal Neovascularization Market Size by Application (2020-2025) & (M USD)
Table 37. Global Choroidal Neovascularization Market Share by Application (2020-2025)
Table 38. Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
Table 39. Global Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 40. Global Choroidal Neovascularization Sales Market Share by Region (2020-2025)
Table 41. Global Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 42. Global Choroidal Neovascularization Market Size Market Share by Region (2020-2025)
Table 43. North America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 44. North America Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 46. Europe Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 49. South America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 50. South America Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 53. Global Choroidal Neovascularization Production (K Units) by Region(2020-2025)
Table 54. Global Choroidal Neovascularization Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Choroidal Neovascularization Revenue Market Share by Region (2020-2025)
Table 56. Global Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Inc. Basic Information
Table 62. Pfizer Inc. Choroidal Neovascularization Product Overview
Table 63. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. SWOT Analysis
Table 66. Pfizer Inc. Recent Developments
Table 67. F. Hoffmann-La Roche Ltd. Basic Information
Table 68. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
Table 69. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. F. Hoffmann-La Roche Ltd. Business Overview
Table 71. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 72. F. Hoffmann-La Roche Ltd. Recent Developments
Table 73. Novartis AG Basic Information
Table 74. Novartis AG Choroidal Neovascularization Product Overview
Table 75. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis AG Business Overview
Table 77. Novartis AG SWOT Analysis
Table 78. Novartis AG Recent Developments
Table 79. Regeneron Pharmaceuticals Inc. Basic Information
Table 80. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
Table 81. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Regeneron Pharmaceuticals Inc. Business Overview
Table 83. Regeneron Pharmaceuticals Inc. Recent Developments
Table 84. Bayer AG Basic Information
Table 85. Bayer AG Choroidal Neovascularization Product Overview
Table 86. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Recent Developments
Table 89. QLT Inc. Basic Information
Table 90. QLT Inc. Choroidal Neovascularization Product Overview
Table 91. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. QLT Inc. Business Overview
Table 93. QLT Inc. Recent Developments
Table 94. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information
Table 95. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
Table 96. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
Table 98. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
Table 99. Promedior Inc. Basic Information
Table 100. Promedior Inc. Choroidal Neovascularization Product Overview
Table 101. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Promedior Inc. Business Overview
Table 103. Promedior Inc. Recent Developments
Table 104. Bausch Health Basic Information
Table 105. Bausch Health Choroidal Neovascularization Product Overview
Table 106. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Bausch Health Business Overview
Table 108. Bausch Health Recent Developments
Table 109. Gilead Sciences Inc Basic Information
Table 110. Gilead Sciences Inc Choroidal Neovascularization Product Overview
Table 111. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Gilead Sciences Inc Business Overview
Table 113. Gilead Sciences Inc Recent Developments
Table 114. Global Choroidal Neovascularization Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Choroidal Neovascularization Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Choroidal Neovascularization Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Choroidal Neovascularization Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Choroidal Neovascularization Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Choroidal Neovascularization Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Choroidal Neovascularization Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Choroidal Neovascularization Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Choroidal Neovascularization Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Choroidal Neovascularization Market Size Comparison by Region (M USD)
Table 5. Global Choroidal Neovascularization Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Choroidal Neovascularization Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Choroidal Neovascularization Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Choroidal Neovascularization Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroidal Neovascularization as of 2024)
Table 10. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Choroidal Neovascularization Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Choroidal Neovascularization Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Choroidal Neovascularization Sales by Type (K Units)
Table 26. Global Choroidal Neovascularization Market Size by Type (M USD)
Table 27. Global Choroidal Neovascularization Sales (K Units) by Type (2020-2025)
Table 28. Global Choroidal Neovascularization Sales Market Share by Type (2020-2025)
Table 29. Global Choroidal Neovascularization Market Size (M USD) by Type (2020-2025)
Table 30. Global Choroidal Neovascularization Market Size Share by Type (2020-2025)
Table 31. Global Choroidal Neovascularization Price (USD/Unit) by Type (2020-2025)
Table 32. Global Choroidal Neovascularization Sales (K Units) by Application
Table 33. Global Choroidal Neovascularization Market Size by Application
Table 34. Global Choroidal Neovascularization Sales by Application (2020-2025) & (K Units)
Table 35. Global Choroidal Neovascularization Sales Market Share by Application (2020-2025)
Table 36. Global Choroidal Neovascularization Market Size by Application (2020-2025) & (M USD)
Table 37. Global Choroidal Neovascularization Market Share by Application (2020-2025)
Table 38. Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
Table 39. Global Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 40. Global Choroidal Neovascularization Sales Market Share by Region (2020-2025)
Table 41. Global Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 42. Global Choroidal Neovascularization Market Size Market Share by Region (2020-2025)
Table 43. North America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 44. North America Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 46. Europe Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 49. South America Choroidal Neovascularization Sales by Country (2020-2025) & (K Units)
Table 50. South America Choroidal Neovascularization Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Choroidal Neovascularization Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Choroidal Neovascularization Market Size by Region (2020-2025) & (M USD)
Table 53. Global Choroidal Neovascularization Production (K Units) by Region(2020-2025)
Table 54. Global Choroidal Neovascularization Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Choroidal Neovascularization Revenue Market Share by Region (2020-2025)
Table 56. Global Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Choroidal Neovascularization Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Pfizer Inc. Basic Information
Table 62. Pfizer Inc. Choroidal Neovascularization Product Overview
Table 63. Pfizer Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. SWOT Analysis
Table 66. Pfizer Inc. Recent Developments
Table 67. F. Hoffmann-La Roche Ltd. Basic Information
Table 68. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Product Overview
Table 69. F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. F. Hoffmann-La Roche Ltd. Business Overview
Table 71. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 72. F. Hoffmann-La Roche Ltd. Recent Developments
Table 73. Novartis AG Basic Information
Table 74. Novartis AG Choroidal Neovascularization Product Overview
Table 75. Novartis AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Novartis AG Business Overview
Table 77. Novartis AG SWOT Analysis
Table 78. Novartis AG Recent Developments
Table 79. Regeneron Pharmaceuticals Inc. Basic Information
Table 80. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Product Overview
Table 81. Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Regeneron Pharmaceuticals Inc. Business Overview
Table 83. Regeneron Pharmaceuticals Inc. Recent Developments
Table 84. Bayer AG Basic Information
Table 85. Bayer AG Choroidal Neovascularization Product Overview
Table 86. Bayer AG Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Bayer AG Business Overview
Table 88. Bayer AG Recent Developments
Table 89. QLT Inc. Basic Information
Table 90. QLT Inc. Choroidal Neovascularization Product Overview
Table 91. QLT Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. QLT Inc. Business Overview
Table 93. QLT Inc. Recent Developments
Table 94. Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information
Table 95. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Product Overview
Table 96. Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Sanwa Kagaku Kenkyusho Co. Ltd. Business Overview
Table 98. Sanwa Kagaku Kenkyusho Co. Ltd. Recent Developments
Table 99. Promedior Inc. Basic Information
Table 100. Promedior Inc. Choroidal Neovascularization Product Overview
Table 101. Promedior Inc. Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Promedior Inc. Business Overview
Table 103. Promedior Inc. Recent Developments
Table 104. Bausch Health Basic Information
Table 105. Bausch Health Choroidal Neovascularization Product Overview
Table 106. Bausch Health Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Bausch Health Business Overview
Table 108. Bausch Health Recent Developments
Table 109. Gilead Sciences Inc Basic Information
Table 110. Gilead Sciences Inc Choroidal Neovascularization Product Overview
Table 111. Gilead Sciences Inc Choroidal Neovascularization Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Gilead Sciences Inc Business Overview
Table 113. Gilead Sciences Inc Recent Developments
Table 114. Global Choroidal Neovascularization Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Choroidal Neovascularization Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Choroidal Neovascularization Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Choroidal Neovascularization Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Choroidal Neovascularization Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Choroidal Neovascularization Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Choroidal Neovascularization Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Choroidal Neovascularization Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Choroidal Neovascularization Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Choroidal Neovascularization Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Choroidal Neovascularization Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Choroidal Neovascularization Market Size (M USD), 2024-2033
Figure 5. Global Choroidal Neovascularization Market Size (M USD) (2020-2033)
Figure 6. Global Choroidal Neovascularization Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Choroidal Neovascularization Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Choroidal Neovascularization Product Life Cycle
Figure 13. Choroidal Neovascularization Sales Share by Manufacturers in 2024
Figure 14. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2024
Figure 15. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Choroidal Neovascularization Revenue in 2024
Figure 18. Industry Chain Map of Choroidal Neovascularization
Figure 19. Global Choroidal Neovascularization Market PEST Analysis
Figure 20. Global Choroidal Neovascularization Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Choroidal Neovascularization Market Share by Type
Figure 27. Sales Market Share of Choroidal Neovascularization by Type (2020-2025)
Figure 28. Sales Market Share of Choroidal Neovascularization by Type in 2024
Figure 29. Market Size Share of Choroidal Neovascularization by Type (2020-2025)
Figure 30. Market Size Share of Choroidal Neovascularization by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Choroidal Neovascularization Market Share by Application
Figure 33. Global Choroidal Neovascularization Sales Market Share by Application (2020-2025)
Figure 34. Global Choroidal Neovascularization Sales Market Share by Application in 2024
Figure 35. Global Choroidal Neovascularization Market Share by Application (2020-2025)
Figure 36. Global Choroidal Neovascularization Market Share by Application in 2024
Figure 37. Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
Figure 38. Global Choroidal Neovascularization Sales Market Share by Region (2020-2025)
Figure 39. Global Choroidal Neovascularization Market Size Market Share by Region (2020-2025)
Figure 40. North America Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 43. North America Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 45. U.S. Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Choroidal Neovascularization Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Choroidal Neovascularization Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Choroidal Neovascularization Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Choroidal Neovascularization Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 53. Europe Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 55. Germany Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Choroidal Neovascularization Sales Market Share by Region in 2024
Figure 67. Asia Pacific Choroidal Neovascularization Market Size Market Share by Region in 2024
Figure 68. China Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 79. South America Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 80. South America Choroidal Neovascularization Market Size and Growth Rate (M USD)
Figure 81. South America Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 82. Brazil Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Choroidal Neovascularization Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Choroidal Neovascularization Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Choroidal Neovascularization Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Choroidal Neovascularization Production Market Share by Region (2020-2025)
Figure 103. North America Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 106. China Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Choroidal Neovascularization Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Choroidal Neovascularization Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Choroidal Neovascularization Market Share Forecast by Type (2026-2033)
Figure 111. Global Choroidal Neovascularization Sales Forecast by Application (2026-2033)
Figure 112. Global Choroidal Neovascularization Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Choroidal Neovascularization
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Choroidal Neovascularization Market Size (M USD), 2024-2033
Figure 5. Global Choroidal Neovascularization Market Size (M USD) (2020-2033)
Figure 6. Global Choroidal Neovascularization Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Choroidal Neovascularization Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Choroidal Neovascularization Product Life Cycle
Figure 13. Choroidal Neovascularization Sales Share by Manufacturers in 2024
Figure 14. Global Choroidal Neovascularization Revenue Share by Manufacturers in 2024
Figure 15. Choroidal Neovascularization Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Choroidal Neovascularization Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Choroidal Neovascularization Revenue in 2024
Figure 18. Industry Chain Map of Choroidal Neovascularization
Figure 19. Global Choroidal Neovascularization Market PEST Analysis
Figure 20. Global Choroidal Neovascularization Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Choroidal Neovascularization Market Share by Type
Figure 27. Sales Market Share of Choroidal Neovascularization by Type (2020-2025)
Figure 28. Sales Market Share of Choroidal Neovascularization by Type in 2024
Figure 29. Market Size Share of Choroidal Neovascularization by Type (2020-2025)
Figure 30. Market Size Share of Choroidal Neovascularization by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Choroidal Neovascularization Market Share by Application
Figure 33. Global Choroidal Neovascularization Sales Market Share by Application (2020-2025)
Figure 34. Global Choroidal Neovascularization Sales Market Share by Application in 2024
Figure 35. Global Choroidal Neovascularization Market Share by Application (2020-2025)
Figure 36. Global Choroidal Neovascularization Market Share by Application in 2024
Figure 37. Global Choroidal Neovascularization Sales Growth Rate by Application (2020-2025)
Figure 38. Global Choroidal Neovascularization Sales Market Share by Region (2020-2025)
Figure 39. Global Choroidal Neovascularization Market Size Market Share by Region (2020-2025)
Figure 40. North America Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 43. North America Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 45. U.S. Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Choroidal Neovascularization Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Choroidal Neovascularization Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Choroidal Neovascularization Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Choroidal Neovascularization Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 53. Europe Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 55. Germany Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Choroidal Neovascularization Sales Market Share by Region in 2024
Figure 67. Asia Pacific Choroidal Neovascularization Market Size Market Share by Region in 2024
Figure 68. China Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 79. South America Choroidal Neovascularization Sales Market Share by Country in 2024
Figure 80. South America Choroidal Neovascularization Market Size and Growth Rate (M USD)
Figure 81. South America Choroidal Neovascularization Market Size Market Share by Country in 2024
Figure 82. Brazil Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Choroidal Neovascularization Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Choroidal Neovascularization Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Choroidal Neovascularization Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Choroidal Neovascularization Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Choroidal Neovascularization Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Choroidal Neovascularization Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Choroidal Neovascularization Production Market Share by Region (2020-2025)
Figure 103. North America Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 106. China Choroidal Neovascularization Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Choroidal Neovascularization Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Choroidal Neovascularization Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Choroidal Neovascularization Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Choroidal Neovascularization Market Share Forecast by Type (2026-2033)
Figure 111. Global Choroidal Neovascularization Sales Forecast by Application (2026-2033)
Figure 112. Global Choroidal Neovascularization Market Share Forecast by Application (2026-2033)
